Jeremy Sugarman1, Damon M Seils2, J Kemp Watson-Ormond2, Kevin P Weinfurt3. 1. Johns Hopkins Berman Institute of Bioethics; Department of Medicine, Johns Hopkins University School of Medicine; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health. 2. Duke Clinical Research Institute. 3. Duke Clinical Research Institute; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine.
Abstract
BACKGROUND: We describe our use of cognitive interviews in developing a measure of "preventive misconception" to demonstrate the importance of this approach to researchers developing surveys in empirical bioethics. The preventive misconception involves research participants' false beliefs about a prevention trial, including beliefs that the interventions being tested will certainly be effective. METHODS: We developed and refined a measure of the preventive misconception using qualitative interviews that focused on cognitive testing of proposed survey items with HIV prevention trial participants. RESULTS: Two main problems emerged during initial interviews. First, the phrase "reduce your risk," used to elicit beliefs about risk reduction from the use of study medications, was interpreted as relating to a reduction of risky behaviors. Second, the phrase "participating in this study," intended to elicit beliefs about trial group assignment, was interpreted as relating to personal behavior changes associated with study participation. Additional interviews using a revised measure were no longer problematic in these ways, and participants felt the response options were appropriate for conveying their answers. CONCLUSIONS: These findings underscore the importance of cognitive testing in developing surveys for empirical bioethics.
BACKGROUND: We describe our use of cognitive interviews in developing a measure of "preventive misconception" to demonstrate the importance of this approach to researchers developing surveys in empirical bioethics. The preventive misconception involves research participants' false beliefs about a prevention trial, including beliefs that the interventions being tested will certainly be effective. METHODS: We developed and refined a measure of the preventive misconception using qualitative interviews that focused on cognitive testing of proposed survey items with HIV prevention trial participants. RESULTS: Two main problems emerged during initial interviews. First, the phrase "reduce your risk," used to elicit beliefs about risk reduction from the use of study medications, was interpreted as relating to a reduction of risky behaviors. Second, the phrase "participating in this study," intended to elicit beliefs about trial group assignment, was interpreted as relating to personal behavior changes associated with study participation. Additional interviews using a revised measure were no longer problematic in these ways, and participants felt the response options were appropriate for conveying their answers. CONCLUSIONS: These findings underscore the importance of cognitive testing in developing surveys for empirical bioethics.
Entities:
Keywords:
Bioethics; Empirical Research; HIV/AIDS; Health Risk Behaviors; Interview; Qualitative Research
Authors: Kevin P Weinfurt; Jennifer S Allsbrook; Joëlle Y Friedman; Michaela A Dinan; Mark A Hall; Kevin A Schulman; Jeremy Sugarman Journal: IRB Date: 2007 Jan-Feb
Authors: Anh Q Nguyen; Saad K Anjum; Samantha E Halpern; Komal Kumar; Sarah E Van Pilsum Rasmussen; Brianna Doby; Ashton A Shaffer; Allan B Massie; Aaron A R Tobian; Dorry L Segev; Jeremy Sugarman; Christine M Durand Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731
Authors: Jeremy Sugarman; Li Lin; Jared M Baeten; Thesla Palanee-Phillips; Elizabeth R Brown; Flavia Matovu Kiweewa; Nyaradzo M Mgodi; Gonasagrie Nair; Samantha Siva; Damon M Seils; Kevin P Weinfurt Journal: AJOB Empir Bioeth Date: 2019-04-19
Authors: Shanti M Seaman; Sarah E Van Pilsum Rasmussen; Anh Q Nguyen; Samantha E Halpern; Susan You; Madeleine M Waldram; Saad K Anjum; Mary Grace Bowring; Abimereki D Muzaale; Darin B Ostrander; Diane Brown; Allan B Massie; Aaron A R Tobian; Macey L Henderson; Faith E Fletcher; Burke Smith; Ada Chao; Nishita Gorupati; Katya Prakash; Saima Aslam; Dong H Lee; Varvara Kirchner; Timothy L Pruett; Ghady Haidar; Kailey Hughes; Maricar Malinis; Sonya Trinh; Dorry L Segev; Jeremy Sugarman; Christine M Durand Journal: J Acquir Immune Defic Syndr Date: 2020-09-01 Impact factor: 3.771